glp 1 gyógyszer vény nélkül GLP-1 Booster kapszula 60 db A GLP-1 agonista gyógyszerek (pl

Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target mendelian randomization and clinical trials

Carbonell C, Mathew Stephen M, Ruan Y, Warkentin MT, Brenner DR

Ismaiel A, Scarlata GGM, Boitos I, et al

(2023): Semaglutide and Cardiovascular Outcomes in Obesity Without Diabetes

Cardiovascular Outcomes: The SELECT Trial Revolution Breakthrough Cardiovascular Evidence The Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity (SELECT) trial represents a paradigm shift in obesity treatment by demonstrating cardiovascular benefits independent of diabetes status

A lot of GLP-1s are being prescribed by untrained in obesity professionals, Levy says